Alzheimer's & Dementia: The Journal of the Alzheimer's Association

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Mechanism of Amyloid Removal in Patients With Alzheimer.
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Modafinil on Dopamine and Dopamine Transporters.
Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: In Vivo Fibrillar β-Amyloid Detected Using [11C]PiB.
DIAGNOSTIC ACCURACY AND CONFIDENCE IN THE CLINICAL DETECTION OF COGNITIVE IMPAIRMENT IN EARLY-STAGE PARKINSON’S DISEASE  Kathryn A. Wyman-Chick, Phillip.
Discriminatory and predictive capabilities of enzyme-linked immunosorbent assay and multiplex platforms in a longitudinal Alzheimer’s disease study  Wesley.
Correlation of 18F-FDG Avid Volumes on Pre–Radiation Therapy and Post–Radiation Therapy FDG PET Scans in Recurrent Lung Cancer  Nadya Shusharina, PhD,
Volume 3, Issue 1, Pages (January 2017)
Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease  Azadeh Karami, Helga Eyjolfsdottir, Swetha.
Relationship between mechanical and metabolic dyssynchrony with left bundle branch block: Evaluation by 18-fluorodeoxyglucose positron emission tomography.
Whole brain white matter changes revealed by multiple diffusion metrics in multiple sclerosis: A TBSS study  Yaou Liu, Yunyun Duan, Yong He, Chunshui.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Preventive Effect of Rifampicin on Alzheimer Disease Needs at Least 450 mg Daily for 1 Year: An FDG-PET Follow-Up Study - DOI: / Fig. 1.
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints  Argonde C. van Harten, Pieter Jelle Visser,
Christine Bredfeldt, Kristen Rice, Lisa Alecxih 
The Pattern of Brain Amyloid Load in Posterior Cortical Atrophy Using 18F-AV45: Is Amyloid the Principal Actor in the Disease Dement Geriatr Cogn Disord.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Alzheimer’s disease core biomarkers and prediction of dementia in MCI: The effect of age at onset  Anna Caroli, Samantha Galluzzi, Clarissa Ferrari, Annapaola.
DATA-DRIVEN TAU-PET COVARIANCE NETWORKS ENHANCE PREDICTION OF RETROSPECTIVE COGNITIVE CHANGE IN ALZHEIMER’S DISEASE  Jacob W. Vogel, Niklas Mattsson,
The global prevalence of dementia: A systematic review and metaanalysis  Martin Prince, Renata Bryce, Emiliano Albanese, Anders Wimo, Wagner Ribeiro, Cleusa.
A multinational study distinguishing Alzheimer's and healthy patients using cerebrospinal fluid tau/Aβ42 cutoff with concordance to amyloid positron emission.
Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment  Sanna-Kaisa Herukka,
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Imaging AD Progression Amyloid Imaging Agents.
Keith A. Josephs, MD, MST, MSc  Mayo Clinic Proceedings 
Volume 10, Issue 3, Pages (January 2015)
Positron Emission Tomography in Lung Cancer
Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer  Ernest Nadal,
Volume 81, Issue 6, Pages (March 2014)
Michael Ewers, Reisa A. Sperling, William E. Klunk, Michael W
PET Imaging of Tau Deposition in the Aging Human Brain
Detection of aortic graft infection by 18-fluorodeoxyglucose positron emission tomography combined with computed tomography  Gustaf Tegler, MD, Jens Sörensen,
Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer 
Figure 4 11C-PK11195-PET scans showing the evolution of neuroinflammation in a patient after stroke Figure 4 | 11C-PK11195-PET scans showing the evolution.
Comparative effects of dexmedetomidine, propofol, sevoflurane, and S-ketamine on regional cerebral glucose metabolism in humans: a positron emission tomography.
Whole body [18F]fluorodeoxyglucose positron emission tomography imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection:
Advances in the War on Alzheimer's
Tharick A. Pascoal, Sulantha Mathotaarachchi, Monica Shin, Andrea L
Imaging pain British Journal of Anaesthesia
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Development of atelectasis and arterial to end-tidal Pco2-difference in a porcine model of pneumoperitoneum  C.M. Strang, T. Hachenberg, F. Fredén, G.
In vivo tau imaging: Obstacles and progress
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Clifford R. Jack, Heather J. Wiste, Stephen D. Weigand, Terry M
Figure 1 Flortaucipir PET MUBADA/PERSI SUVr at baseline, 9 and 18 months for individual subjects. Each subject is ... Figure 1 Flortaucipir PET MUBADA/PERSI.
Regional cerebral metabolic rate (positron emission tomography) during inhalation of nitrous oxide 50% in humans  P. Reinstrup, E. Ryding, T. Ohlsson,
Volume 81, Issue 6, Pages (March 2014)
Prevalence and incidence of clinically diagnosed Alzheimer's disease dementia from 1994 to 2012 in a population study  Kumar B. Rajan, Jennifer Weuve,
Positron emission tomography study of regional cerebral blood flow and flow– metabolism coupling during general anaesthesia with xenon in humans†   S.
[18F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-β.
Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease  Antoine Leuzy, Elena Rodriguez-Vieitez,
LIFESPAN OF ONE FOCUSED ULTRASOUND MEDIATED BLOOD-BRAIN BARRIER TREATMENT IN A MOUSE MODEL OF ALZHEIMER'S DISEASE  Charissa Poon, Kullervo Hynynen  Alzheimer's.
Indium 111—labeled platelet deposition in woven and knitted Dacron bifurcated aortic grafts with the same patient as a clinical model  Francis Robicsek,
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability.
A 22-single nucleotide polymorphism Alzheimer's disease risk score correlates with family history, onset age, and cerebrospinal fluid Aβ42  Kristel Sleegers,
Shruti Mishra, Brian Andrew Gordon, Karl A
Comparison of visual and quantitative florbetapir-PET reads in subjects with early Alzheimer's disease for assessing amyloid burden  Bradley Wyman, Yahong.
Added value of 11C-PiB-PET imaging in the diagnosis of Alzheimer's disease  Kristian Frederiksen, Anne-Mette Hejl, Ian Law, Steen Hasselbalch, Gunhild.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
Cerebral hypoperfusion is not associated with an increase in amyloid β pathology in middle-aged or elderly people  Oskar Hansson, Sebastian Palmqvist,
Brain amyloid deposition and metabolism in early and late mild cognitive impairment  Jared Rowley, Liyong Wu, Sara Mohades, Marina Dauar, Antoine Leuzy,
Fig. 2. Correlation between Aβ42 and Aβ40 levels in iNPH, AD, and CN subjects. The scatter plot shows the correlation between Aβ42 and Aβ40 levels. Representative.
Suzanne E. Schindler, Julia D. Gray, Brian A
A nonhuman primate model of early Alzheimer's disease pathologic change: Implications for disease pathogenesis  Caitlin S. Latimer, Carol A. Shively,
Michael Navitsky, Abhinay D. Joshi, Michael D. Devous, Michael J
Figure 2 Aβ-PET scans obtained using different tracers
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER.
Lack of FDG Uptake in Small Cell Carcinoma Associated with ANNA-1 Positive Paraneoplastic Autonomic Neuropathy  Matthew S. Block, MD, PhD, Robert Vassallo,
Presentation transcript:

Alzheimer's & Dementia: The Journal of the Alzheimer's Association Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease  Antoine Leuzy, Elena Rodriguez-Vieitez, Laure Saint-Aubert, Konstantinos Chiotis, Ove Almkvist, Irina Savitcheva, My Jonasson, Mark Lubberink, Anders Wall, Gunnar Antoni, Agneta Nordberg  Alzheimer's & Dementia: The Journal of the Alzheimer's Association  DOI: 10.1016/j.jalz.2017.11.008 Copyright © 2017 Terms and Conditions

Fig. 1 Linear regression plots and voxelwise maps showing the relationship between THK5317 perfusion measures and glucose metabolism at baseline and follow-up. Regional correlations between THK5317 p-SUVR and FDG SUVR, THK5317 R1 and FDG SUVR, and between THK5317 perfusion measures at baseline are shown in (A, B, and C), respectively. Regional correlations for the same pairings at follow-up are shown in (G, H, and I). Voxelwise correlations are shown in (D–F) and (J–L). Abbreviations: FDG, [18F]fluorodeoxyglucose; p-SUVR, early-frame standardized uptake value ratio; R1, reference regions; THK5317, [18F]THK5317. Alzheimer's & Dementia: The Journal of the Alzheimer's Association DOI: (10.1016/j.jalz.2017.11.008) Copyright © 2017 Terms and Conditions

Fig. 2 Group-level average maps, at baseline (top row) and follow-up (bottom row), for THK5317 p-SUVR (A), THK5317 R1 (B), FDG SUVR (C), and THK5317 DVR (D). Abbreviations: DVR, distribution volume ratio; FDG, [18F]fluorodeoxyglucose; p-SUVR, early-frame standardized uptake value ratio; R1, reference regions; THK5317, [18F]THK5317. Alzheimer's & Dementia: The Journal of the Alzheimer's Association DOI: (10.1016/j.jalz.2017.11.008) Copyright © 2017 Terms and Conditions

Fig. 3 Group-level annual percentage change maps for perfusion, metabolism, and tau. Annual percentage change for each PET measure was created for each subject as follows: {[(Follow-up − Baseline)/Baseline]/Time interval between scans (years)} × 100%. Surface projection images showing annual percentage change for THK5317 p-SUVR (A), THK5317 R1 (B), FDG SUVR (C), and THK5317 DVR (D). Spatial overlap of annual percentage change images binarized using the average test-retest repeatability of THK5317 perfusion measures is shown for THK5317 perfusion measures (E), THK5317 p-SUVR and FDG SUVR (F), and THK5317 R1 and FDG SUVR (G). For the overlap between perfusion and THK5317 DVR (H), THK5317 p-SUVR was chosen because of the potentially greater clinical applicability of p-SUVR due the fact that it does not require dynamic imaging and the fact that identical overlap was obtained when using THK5317 R1. Abbreviations: DVR, distribution volume ratio; FDG, [18F]fluorodeoxyglucose; PET, positron emission tomography; p-SUVR, early-frame standardized uptake value ratio; R1, reference regions; THK5317, [18F]THK5317. Alzheimer's & Dementia: The Journal of the Alzheimer's Association DOI: (10.1016/j.jalz.2017.11.008) Copyright © 2017 Terms and Conditions

Fig. 4 Subgroup-level annual percentage change maps for perfusion, metabolism, and tau. Surface projection images showing annual percentage change in PET measures in prodromal AD and AD dementia patients: THK5317 p-SUVR (A), THK5317 R1 (B), FDG SUVR (C), and THK5317 DVR (D). Spatial overlap of annual percentage change images binarized using the average test-retest repeatability of THK5317 perfusion measures is shown in prodromal AD and AD dementia patients for THK5317 perfusion measures (E), THK5317 p-SUVR and FDG SUVR (F), and THK5317 R1 and FDG SUVR (G). For the overlap between perfusion and THK5317 DVR (H), THK5317 p-SUVR was chosen because of the potentially greater clinical applicability of p-SUVR due the fact that it does not require dynamic imaging and the fact that identical overlap was obtained when using THK5317 R1. Images in panels (E–H) are in radiologic orientation. Abbreviations: AD, Alzheimer's disease; DVR, distribution volume ratio; FDG, [18F]fluorodeoxyglucose; PET, positron emission tomography; p-SUVR, early-frame standardized uptake value ratio; R1, reference regions; THK5317, [18F]THK5317. Alzheimer's & Dementia: The Journal of the Alzheimer's Association DOI: (10.1016/j.jalz.2017.11.008) Copyright © 2017 Terms and Conditions